** Shares of Invion rise as much as 130.6% to A$0.415, posting their biggest intraday percentage gain since Oct. 28, 2021

** Stock hits its highest level since July 16

** Cancer treatment developer says the first patient has been dosed in the early-stage trial of its light absorbing material "INV043", aimed to treat non-melanoma skin cancer

** About 483,000 shares change hands, compared with the 30-day average volume of around 37,000

** Stock trims YTD losses to 30%, including session's move

(Reporting by Aaditya Govind Rao in Bengaluru)

((Aaditya.govindrao@thomsonreuters.com))